Literature DB >> 10997886

Cytogenetic findings in a population-based series of 787 childhood acute lymphoblastic leukemias from the Nordic countries. The NOPHO Leukemia Cytogenetic Study Group.

E Forestier1, B Johansson, G Borgström, G Kerndrup, J Johansson, S Heim.   

Abstract

Different types of leukemia are characterized by different patterns of nonrandom chromosomal aberrations, but the frequencies with which the various karyotypic subtypes are seen differ among cytogenetic laboratories, countries, and geographic regions. During the 12-yr period 1986-1997, a total of 2054 children (< 15 yr of age) were diagnosed with acute lymphoblastic leukemia (ALL) in the five Nordic countries (Denmark, Finland, Iceland, Norway, and Sweden). Cytogenetic analyses were successfully performed in 1372 patients, 787 (57%) of whom displayed clonal chromosomal abnormalities. ALL with > or = 47 chromosomes was the most frequent cytogenetic subgroup (63%), with massive hyperdiploidy (> or = 52 chromosomes) and chromosome numbers in the tri- and tetraploid range, constituting 46% of all abnormal cases. ALL-associated translocations were found at low frequencies [11q23 translocations in 3.7%, t(9;22)(q34;q11) or del(22q) in 2.2%, t(4; 11)(q21;q23) in 2.0%, t(11;19)(q23;p13) in 1.40%, t(1;19)(q23;p13) in 1.3%, and t(8;14)(q24;q32) in 1%]. Two rearrangements not previously reported in childhood ALL, but recurrent in this population-based material, were identified: der(7;9)(q10;q10) and t(9;12)(q22;p11-12), the molecular genetic consequences of which are unknown. Hyperdiploid childhood leukemias, especially those with a high hyperdiploid modal number, thus seem to be more frequent and ALL-specific translocations less frequent in the Nordic countries than in other geographic regions. Although technical differences among laboratories cannot be ruled out as a cause of at least some of the frequency differences observed compared with previous studies, systematic differences in exposure to environmental oncogenic factors or in geographic/ethnic origin are an intriguing possibility.

Entities:  

Mesh:

Year:  2000        PMID: 10997886     DOI: 10.1034/j.1600-0609.2000.90103.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  8 in total

1.  Biological and clinical features of trisomy 21 in adult patients with acute myeloid leukemia.

Authors:  Paolo Strati; Naval Daver; Farhad Ravandi; Naveen Pemmaraju; Sherry Pierce; Guillermo Garcia-Manero; Aziz Nazha; Tapan Kadia; Elias Jabbour; Gautam Borthakur; Stefan Faderl; Alfonso Quintas-Cardama; Hagop Kantarjian; Jorge Cortes
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-08-19

Review 2.  Cytogenetics and molecular genetics of acute lymphoblastic leukemia.

Authors:  Krzysztof Mrózek; David P Harper; Peter D Aplan
Journal:  Hematol Oncol Clin North Am       Date:  2009-10       Impact factor: 3.722

3.  Cytogenetic and Molecular Findings in Children with Acute Lymphoblastic Leukemia: Experience of a Single Institution in Argentina.

Authors:  Mariela C Coccé; Cristina N Alonso; Jorge G Rossi; Andrea R Bernasconi; Maria A Rampazzi; Maria S Felice; Patricia L Rubio; Silvia Eandi Eberle; Adriana Medina; Marta S Gallego
Journal:  Mol Syndromol       Date:  2015-10-07

4.  Cytogenetic and Fluorescence in situ Hybridization Profile of Pediatric Acute Lymphoblastic Leukemia in a University Hospital in South India.

Authors:  Latha Sneha Magatha; Julius Xavier Scott; Gayathri Subramaniam; Thirugnanasambandan Chandrasekaran; Solomon Franklin Durairaj Paul; Teena Koshy
Journal:  Med Princ Pract       Date:  2021-07-07       Impact factor: 1.927

Review 5.  The Role of Chromosomal Instability in Cancer and Therapeutic Responses.

Authors:  Natalia Vargas-Rondón; Victoria E Villegas; Milena Rondón-Lagos
Journal:  Cancers (Basel)       Date:  2017-12-28       Impact factor: 6.639

6.  Is hyperdiploidy a favorable cytogenetics in adults with B-lymphoblastic leukemia?

Authors:  Zhining Chen; Yi Sun; Wei Xie; Sa A Wang; Shimin Hu; Shaoying Li; Zhenya Tang; Gokce Toruner; L Jeffrey Medeiros; Guilin Tang
Journal:  Cancer Med       Date:  2019-06-07       Impact factor: 4.452

Review 7.  B-ALL Complexity: Is Targeted Therapy Still A Valuable Approach for Pediatric Patients?

Authors:  Stefano Ratti; Annalisa Lonetti; Matilde Y Follo; Francesca Paganelli; Alberto M Martelli; Francesca Chiarini; Camilla Evangelisti
Journal:  Cancers (Basel)       Date:  2020-11-24       Impact factor: 6.639

8.  Minimal Residual Disease Detection and Evolved IGH Clones Analysis in Acute B Lymphoblastic Leukemia Using IGH Deep Sequencing.

Authors:  Jinghua Wu; Shan Jia; Changxi Wang; Wei Zhang; Sixi Liu; Xiaojing Zeng; Huirong Mai; Xiuli Yuan; Yuanping Du; Xiaodong Wang; Xueyu Hong; Xuemei Li; Feiqiu Wen; Xun Xu; Jianhua Pan; Changgang Li; Xiao Liu
Journal:  Front Immunol       Date:  2016-10-04       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.